Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01028625 · ClinicalTrials.gov registry record · NA

Depression and Self-care in Heart Failure

A NA study of Depression and Heart Failure, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
158
Enrollment target
1
Study location

NCT01028625: Completed NA study of Depression and Heart Failure, sponsored by Washington University School of Medicine.

NCT01028625 is a NA study of Depression and Heart Failure that has completed, run by Washington University School of Medicine. The registered enrollment target is 158 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01028625, a NA study of Depression and Heart Failure, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
158 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test whether Cognitive Behavior Therapy (CBT) plus heart failure self-care education is superior to "usual care" for depression.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavior Therapy
  • OTHER Heart Failure Self-care Education

Study Locations (1)

Missouri

  • Washington University School of Medicine Behavioral Medicine Center - St Louis

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2010-01
Est. Completion 2014-04
Phase NA

What the finished NCT01028625 record still lists

NCT01028625 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (80% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavior Therapy is the first listed.

NCT01028625 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT01028625 about?

NCT01028625 is a clinical study titled "Depression and Self-care in Heart Failure". The purpose of the study is to test whether Cognitive Behavior Therapy (CBT) plus heart failure self-care education is superior to "usual care" for depression.

What is the current status of trial NCT01028625?

This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2010-01. Estimated completion is 2014-04.

What conditions does trial NCT01028625 study?

This clinical trial studies the following conditions: Depression, Heart Failure.

What interventions are being tested in trial NCT01028625?

The interventions under investigation include: Cognitive Behavior Therapy (BEHAVIORAL), Heart Failure Self-care Education (OTHER).

Who is sponsoring clinical trial NCT01028625?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01028625 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01028625's enrollment target sits among peer trials

158 243rd of 679 higher than 437 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486833 · 158 participants · Phase 1

    Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

  • NCT04697966 · 158 participants · NA

    Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

  • NCT04969835 · 158 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

  • NCT05230732 · 158 participants · NA

    Neuromodulation of Inflammation and Endothelial Function

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01028625, the US trial registry maintained by the National Library of Medicine. NCT01028625 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.